156 related articles for article (PubMed ID: 25918881)
1. Oxidative stress in hypertension: mechanisms and therapeutic opportunities.
Brito R; Castillo G; González J; Valls N; Rodrigo R
Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):325-35. PubMed ID: 25918881
[TBL] [Abstract][Full Text] [Related]
2. Vascular oxidative stress, nitric oxide and atherosclerosis.
Li H; Horke S; Förstermann U
Atherosclerosis; 2014 Nov; 237(1):208-19. PubMed ID: 25244505
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications.
Higashi Y; Maruhashi T; Noma K; Kihara Y
Trends Cardiovasc Med; 2014 May; 24(4):165-9. PubMed ID: 24373981
[TBL] [Abstract][Full Text] [Related]
7. Essential hypertension and oxidative stress: New insights.
González J; Valls N; Brito R; Rodrigo R
World J Cardiol; 2014 Jun; 6(6):353-66. PubMed ID: 24976907
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and oxidative stress in vascular disease.
Förstermann U
Pflugers Arch; 2010 May; 459(6):923-39. PubMed ID: 20306272
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
[TBL] [Abstract][Full Text] [Related]
10. Is oxidative stress a therapeutic target in cardiovascular disease?
Münzel T; Gori T; Bruno RM; Taddei S
Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and endothelial dysfunction in hypertension.
Schulz E; Gori T; Münzel T
Hypertens Res; 2011 Jun; 34(6):665-73. PubMed ID: 21512515
[TBL] [Abstract][Full Text] [Related]
12. The molecular sources of reactive oxygen species in hypertension.
Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and hypertension: current concepts.
Briones AM; Touyz RM
Curr Hypertens Rep; 2010 Apr; 12(2):135-42. PubMed ID: 20424957
[TBL] [Abstract][Full Text] [Related]
14. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
Schulman IH; Zhou MS; Raij L
J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
16. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
Gao L; Mann GE
Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and vascular remodelling.
Fortuño A; San José G; Moreno MU; Díez J; Zalba G
Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
[TBL] [Abstract][Full Text] [Related]
18. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
19. [Antioxidant action and sympatho-inhibitory effect of ARB].
Hitooks Y; Sunagawa K
Nihon Rinsho; 2006 Jul; 64 Suppl 5():487-92. PubMed ID: 16897884
[No Abstract] [Full Text] [Related]
20. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M
Atherosclerosis; 2011 May; 216(1):44-53. PubMed ID: 21316056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
